Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BIO BIO.B | Bio-Rad A Common Stock | Options Exercise | $0 | +308 | $0.00 | 308 | Apr 22, 2025 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BIO BIO.B | Restricted Stock Units | Award | $0 | +407 | $0.00 | 407 | Apr 22, 2025 | Bio-Rad A Common Stock | 407 | $0.00 | Direct | F2, F3 | |
transaction | BIO BIO.B | Restricted Stock Units | Options Exercise | $0 | -308 | -100% | $0.00 | 0 | Apr 22, 2025 | Bio-Rad A Common Stock | 308 | $0.00 | Direct | F2, F4 |
Id | Content |
---|---|
F1 | Shares of Class A common stock acquired on the vesting of restricted stock units. |
F2 | Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. |
F3 | The restricted stock units will vest 100% on the earlier of the first anniversary of the grant date or the date of the company's next annual meeting of stockholders. |
F4 | On September 6, 2024, the reporting person was granted 308 restricted stock units, vesting at 100% on the earlier of the first anniversary of the grant date or the date of the Company's next annual stockholder meeting following the grant date. |